327 related articles for article (PubMed ID: 27093577)
21. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
[TBL] [Abstract][Full Text] [Related]
22. 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity.
Rocha Gda G; Oliveira RR; Kaplan MA; Gattass CR
Eur J Pharmacol; 2014 Oct; 741():140-9. PubMed ID: 25111243
[TBL] [Abstract][Full Text] [Related]
23. Influence of glutathione and glutathione S-transferases on DNA interstrand cross-link formation by 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine, the active anticancer moiety generated by laromustine.
Penketh PG; Patridge E; Shyam K; Baumann RP; Zhu R; Ishiguro K; Sartorelli AC
Chem Res Toxicol; 2014 Aug; 27(8):1440-9. PubMed ID: 25012050
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibitors of glutathione transferase P1 with trioxane structure as anticancer agents.
Bräutigam M; Teusch N; Schenk T; Sheikh M; Aricioglu RZ; Borowski SH; Neudörfl JM; Baumann U; Griesbeck AG; Pietsch M
ChemMedChem; 2015 Apr; 10(4):629-39. PubMed ID: 25694385
[TBL] [Abstract][Full Text] [Related]
25. A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo.
Tarasenko N; Cutts SM; Phillips DR; Berkovitch-Luria G; Bardugo-Nissim E; Weitman M; Nudelman A; Rephaeli A
Biochem Pharmacol; 2014 Mar; 88(2):158-68. PubMed ID: 24463168
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
27. Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistance.
Cutts SM; Nudelman A; Pillay V; Spencer DM; Levovich I; Rephaeli A; Phillips DR
Oncol Res; 2005; 15(4):199-213. PubMed ID: 17822280
[TBL] [Abstract][Full Text] [Related]
28. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells.
Seow HA; Penketh PG; Shyam K; Rockwell S; Sartorelli AC
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9282-7. PubMed ID: 15964988
[TBL] [Abstract][Full Text] [Related]
29. Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin.
Abu Ajaj K; Graeser R; Kratz F
Breast Cancer Res Treat; 2012 Jul; 134(1):117-29. PubMed ID: 22228402
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi.
Goto S; Ihara Y; Urata Y; Izumi S; Abe K; Koji T; Kondo T
FASEB J; 2001 Dec; 15(14):2702-14. PubMed ID: 11726546
[TBL] [Abstract][Full Text] [Related]
31. Intracellular glutathione level and efflux in human melanoma and cervical cancer cells differing in doxorubicin resistance.
Drozd E; Gruber B; Marczewska J; Drozd J; Anuszewska E
Postepy Hig Med Dosw (Online); 2016 Apr; 70():319-28. PubMed ID: 27117108
[TBL] [Abstract][Full Text] [Related]
32. Glutathione transferases and development of new principles to overcome drug resistance.
Sau A; Pellizzari Tregno F; Valentino F; Federici G; Caccuri AM
Arch Biochem Biophys; 2010 Aug; 500(2):116-22. PubMed ID: 20494652
[TBL] [Abstract][Full Text] [Related]
33. Cellular response to a glutathione S-transferase P1-1 activated prodrug.
Rosario LA; O'Brien ML; Henderson CJ; Wolf CR; Tew KD
Mol Pharmacol; 2000 Jul; 58(1):167-74. PubMed ID: 10860939
[TBL] [Abstract][Full Text] [Related]
34. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
35. Mechanism, structure-activity studies, and potential applications of glutathione S-transferase-catalyzed cleavage of sulfonamides.
Zhao Z; Koeplinger KA; Peterson T; Conradi RA; Burton PS; Suarato A; Heinrikson RL; Tomasselli AG
Drug Metab Dispos; 1999 Sep; 27(9):992-8. PubMed ID: 10460797
[TBL] [Abstract][Full Text] [Related]
36. Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.
Zhang Y; Xiao C; Li M; Chen J; Ding J; He C; Zhuang X; Chen X
Macromol Biosci; 2013 May; 13(5):584-94. PubMed ID: 23420692
[TBL] [Abstract][Full Text] [Related]
37. Glutathione Transferases: Potential Targets to Overcome Chemoresistance in Solid Tumors.
Pljesa-Ercegovac M; Savic-Radojevic A; Matic M; Coric V; Djukic T; Radic T; Simic T
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30487385
[TBL] [Abstract][Full Text] [Related]
38. Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo.
Li S; Li C; Jin S; Liu J; Xue X; Eltahan AS; Sun J; Tan J; Dong J; Liang XJ
Biomaterials; 2017 Nov; 144():119-129. PubMed ID: 28834763
[TBL] [Abstract][Full Text] [Related]
39. Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics.
Chekhun VF; Borikun TV; Lukianova NY
Exp Oncol; 2016 Mar; 38(1):26-30. PubMed ID: 27031715
[TBL] [Abstract][Full Text] [Related]
40. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
